Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol and Labetalol in Electroconvulsive Therapy
IRCT20160307026950N19Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of esmolol and labetalol in hypertension (HTN) and tachyarrhythmia (2 arms), sponsored by Isfahan University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
esmolollabetalol
03
Conditions
hypertension (HTN)tachyarrhythmia
Beyond the preview
Go deeper on IRCT20160307026950N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N19.